Market revenue in 2023 | USD 8.2 million |
Market revenue in 2030 | USD 17.2 million |
Growth rate | 11.2% (CAGR from 2023 to 2030) |
Largest segment | Dual channel |
Fastest growing segment | Single Channel |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Single Channel, Dual Channel |
Key market players worldwide | Abbott Laboratories, Medtronic PLC, Boston Scientific Corp, Nexstim Oyj Registered Shs Reg S, LivaNova PLC, NeuroPace Inc |
Dual channel was the largest segment with a revenue share of 58.54% in 2023. Horizon Databook has segmented the Singapore deep brain stimulation devices market based on single channel, dual channel covering the revenue growth of each sub-segment from 2018 to 2030.
Moreover, this country has an open trade policy, thus it has no barriers to trade and custom duties on medical devices. Thus, adoption of neurostimulators for deep brain stimulation is expected to grow in the coming years.
Furthermore, Singapore offers universal coverage and large government subsidies are available to assist patients with critical care needs although private & government administered medical insurance is available.
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account